TECX Tectonic Therapeutic, Inc.

$34.91

Tectonic Therapeutic, Inc. (TECX) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $1.38 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +13.4% since its last earnings release on August 6, 2026.

Tectonic Therapeutic Beat Consensus Estimates
Thursday, August 6, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:00 PM ET
Earnings Whisper
-
vs ($1.38)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $34.38

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Tectonic Therapeutic, Inc.

Tectonic Therapeutic Inc. is a biotechnology company developing GPCR -targeted therapeutic proteins. Tectonic Therapeutic Inc., formerly known as AVROBIO Inc., is based in CAMBRIDGE, Mass.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow